DIA:NYE-SPDR Dow Jones Industrial Average ETF Trust (USD)

ETF | Large Value |

Last Closing

USD 429.37

Change

-3.27 (-0.76)%

Market Cap

N/A

Volume

2.70M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Large Value

Symbol Name Price(Change) Market Cap
SCHD Schwab U.S. Dividend Equity ET..

-0.34 (-1.18%)

USD 64.18B
DGRO iShares Core Dividend Growth E..

-0.57 (-0.89%)

USD 30.75B
FNDX Schwab Fundamental U.S. Large ..

-0.19 (-0.78%)

USD 17.45B
SCHV Schwab U.S. Large-Cap Value ET..

-0.26 (-0.95%)

USD 12.08B
SPYD SPDR® Portfolio S&P 500 High ..

-0.60 (-1.30%)

USD 6.94B
VOOV Vanguard S&P 500 Value Index F..

-1.62 (-0.83%)

USD 5.25B
FDVV Fidelity® High Dividend ETF

-0.24 (-0.46%)

USD 3.89B
SPHD Invesco S&P 500® High Dividen..

-0.58 (-1.14%)

USD 3.51B
IWX iShares Russell Top 200 Value ..

-0.60 (-0.72%)

USD 3.25B
LRGF iShares U.S. Equity Factor ETF

-0.14 (-0.23%)

USD 2.24B

ETFs Containing DIA

BAMO 20.71 % 0.00 %

N/A

N/A
DCAP Unity Wealth Partners Dyn.. 15.19 % 0.00 %

-0.13 (-0.60%)

USD 3.64M
DIP 9.65 % 0.00 %

N/A

N/A
LEXI Alexis Practical Tactical.. 5.52 % 0.00 %

-0.09 (-0.60%)

USD 0.09B
DOCG:LSE L&G Healthcare Breakthrou.. 1.72 % 0.00 %

-7.90 (-0.60%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.72 % 0.00 %

-0.14 (-0.60%)

USD 0.07B
XMLH:XETRA L&G Healthcare Breakthrou.. 1.71 % 0.00 %

-0.09 (-0.60%)

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.71 % 0.00 %

+0.10 (+-0.60%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.71 % 0.00 %

-0.03 (-0.60%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Large Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.93% 28% F 66% D+
Dividend Return -21.41% 67% D+ 66% D+
Total Return -7.48% 16% F 29% F
Trailing 12 Months  
Capital Gain 30.38% 46% F 68% D+
Dividend Return -24.29% 67% D+ 66% D+
Total Return 6.09% 15% F 37% F
Trailing 5 Years  
Capital Gain 60.07% 71% C- 75% C
Dividend Return -21.94% 33% F 64% D
Total Return 38.13% 37% F 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.73% 44% F 69% C-
Dividend Return 12.33% 31% F 67% D+
Total Return 1.60% 19% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 14.86% 73% C 66% D+
Risk Adjusted Return 82.96% 63% D 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.